97-30912. Agency Information Collection Activities: Proposed Collection; Comment Request  

  • [Federal Register Volume 62, Number 227 (Tuesday, November 25, 1997)]
    [Notices]
    [Page 62775]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-30912]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 97N-0376]
    
    
    Agency Information Collection Activities: Proposed Collection; 
    Comment Request
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
    proposed collection of information has been submitted to the Office of 
    Management and Budget (OMB) for emergency processing under the 
    Paperwork Reduction Act of 1995 (the PRA). The purpose of the proposed 
    collection of information, a two-part telephone survey of tobacco 
    retailers, is to assess the effectiveness of an advertising campaign 
    aimed at increasing retailers' awareness of, and motivating retailers 
    to comply with, new regulations that prohibit retailers from selling 
    cigarettes and smokeless tobacco to persons younger than 18 years of 
    age and require retailers to verify, by means of photographic 
    identification containing the bearer's date of birth, the age of every 
    purchaser who is younger than 27 years old. The first phase of the 
    survey must be completed by December 31, 1997.
    
    DATES: Submit written comments on the collection of information by 
    December 5, 1997.
    
    ADDRESSES: Submit written comments on the collection of information to 
    the Office of Information and Regulatory Affairs, OMB, New Executive 
    Office Bldg., 725 17th St. NW., rm. 10235, Washington, DC 20503, Attn: 
    Desk Officer for FDA. All comments should be identified with the docket 
    number found in brackets in the heading of this document.
    
    FOR FURTHER INFORMATION CONTACT: Karen L. Nelson, Office of Information 
    Resources Management (HFA-250), Food and Drug Administration, 5600 
    Fishers Lane, rm. 16B-18, Rockville, MD 20857, 301-827-1482.
    
    SUPPLEMENTARY INFORMATION: With respect to the following collection of 
    information, FDA invites comments on: (1) Whether the proposed 
    collection of information is necessary for the proper performance of 
    FDA's functions, including whether the information will have practical 
    utility; (2) the accuracy of FDA's estimate of the burden of the 
    proposed collection of information, including the validity of the 
    methodology and assumptions used; (3) ways to enhance the quality, 
    utility, and clarity of the information to be collected; and (4) ways 
    to minimize the burden of the collection of information on respondents, 
    including through the use of automated collection techniques, when 
    appropriate, and other forms of information technology.
    
    Tobacco Retailer Tracking Survey
    
        On February 28, 1997, new Federal regulations at 21 CFR part 897 
    went into effect that prohibit retailers from selling cigarettes and 
    smokeless tobacco to persons younger than 18 years of age, and require 
    retailers to verify, by means of photographic identification, the age 
    of purchasers younger than 27 years old. FDA is planning to conduct a 
    pilot advertising will campaign, in one State, aimed at raising 
    retailers' awareness of the new regulations, and motivating retailers 
    to comply. The campaign will target persons who sell cigarettes or 
    smokeless tobacco to consumers for their personal use, including clerks 
    and cashiers in grocery and convenience stores, pharmacies and drug 
    stores, gas stations, liquor stores, taverns and bars, and tobacco 
    stores. As part of the pilot, FDA is proposing to conduct a two-part 
    telephone survey of tobacco retailers to measure their awareness of, 
    and self-reported compliance with, the new regulations before and after 
    exposure to the advertising campaign in the test State. FDA also would 
    study levels of awareness and self-reported compliance among tobacco 
    retailers in a control State matched demographically with the test 
    State. Retailers in the control State would not be exposed to the media 
    campaign, and FDA would not be actively conducting compliance checks 
    before awareness and self-reported levels of compliance are measured.
        A random sample of 1,350 tobacco retailers in the test State (675 
    for each phase) and 300 tobacco retailers in the control State would be 
    selected for a telephone interview. All interviewing would be conducted 
    by a single market research firm that would employ computer-aided 
    telephone interviewing technology to expedite the fieldwork and ensure 
    accuracy. FDA plans to use the results of the survey in designing a 
    nationwide advertising campaign that would help to reduce youth access 
    to cigarettes and smokeless tobacco. Under 21 U.S.C. 393(b)(2)(C), FDA 
    is authorized to conduct surveys and other research relating to its 
    responsibilities under the Federal Food, Drug, and Cosmetic Act.
        FDA estimates the burden of this collection of information as 
    follows:
    
                                      Table 1.--Estimated Annual Reporting Burden1                                  
    ----------------------------------------------------------------------------------------------------------------
                                                          Annual                                                    
                   No. of Respondents                  Frequency per   Total Annual      Hours per      Total Hours 
                                                         Response        Responses       Response                   
    ----------------------------------------------------------------------------------------------------------------
    1,650 survey                                            1           1,650                .2           330       
    Total                                                               1,650                             330       
    ----------------------------------------------------------------------------------------------------------------
    \1\ There are no capital costs or operating and maintenance costs associated with this collection of            
      information.                                                                                                  
    
        FDA has requested emergency processing of this proposed collection 
    of information under section 3507(j) of the PRA and 5 CFR 1320.13. This 
    information is needed by December 31, 1997, and is essential to the 
    agency's mission. The use of normal PRA clearance procedures would be 
    likely to result in the prevention or disruption of this collection of 
    information.
    
        Dated: November 19, 1997.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 97-30912 Filed 11-24-97; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
11/25/1997
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
97-30912
Dates:
Submit written comments on the collection of information by December 5, 1997.
Pages:
62775-62775 (1 pages)
Docket Numbers:
Docket No. 97N-0376
PDF File:
97-30912.pdf